Skip to main content
NCBI home page
The Journal of Experimental Medicine logoLink to The Journal of Experimental Medicine
. 1978 Mar 1;147(3):912–922. doi: 10.1084/jem.147.3.912

Autologous leukemia-specific T-cell-mediated lymphocytotoxicity in patients with acute myelogenous leukemia

PMCID: PMC2184196  PMID: 305461

Abstract

Short-term culture of acute myelogenous leukemia patient's remission lymphocytes with inactivated autologous leukemic blast cells plus allogeneic lymphocytes, generated effector T lymphocytes which were cytotoxic for the specific autologous blast cell in 11 of 14 patients studied. Experiments using Daudi and Molt 4 lymphoblastoid cell lines as third-party helper cell suggest that an HLA D locus incompatability is necessary to provide effective help in this system. Cold target inhibition experiments, crossover studies between pairs of patients, and experiments with allogeneic leukemic blast cells as priming stimulus suggest that the target antigen is only present on the specific autologous blast cell.

Full Text

The Full Text of this article is available as a PDF (698.1 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Brochier J., Abou-Hamed Y. A., Gueho J. P., Revillard J. P. Study of human T and B lymphocytes with heterologous antisera. I Preparation, specificity and properties of antisera. Immunology. 1976 Nov;31(5):749–758. [PMC free article] [PubMed] [Google Scholar]
  2. Crowther D., Beard M. E., Bateman C. J., Sewell R. L. Factors influencing prognosis in adults with acute myelogenous leukaemia. Br J Cancer. 1975 Oct;32(4):456–464. doi: 10.1038/bjc.1975.247. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Crowther D., Powles R. L., Bateman C. J., Beard M. E., Gauci C. L., Wrigley P. F., Malpas J. S., Fairley G. H., Scott R. B. Management of adult acute myelogenous leukaemia. Br Med J. 1973 Jan 20;1(5846):131–137. doi: 10.1136/bmj.1.5846.131. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Currie G. A. Eighty years of immunotherapy: a review of immunological methods used for the treatment of human cancer. Br J Cancer. 1972 Jun;26(3):141–153. doi: 10.1038/bjc.1972.21. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Eijsvoogel V. P., du Bois M. J., Meinesz A., Bierhorst-Eijlander A., Zeylemaker W. P., Schellekens P. T. The specificty and the activation mechanism of cell-mediated lympholysis (CML) in man. Transplant Proc. 1973 Dec;5(4):1675–1678. [PubMed] [Google Scholar]
  6. Eijsvoogel V. P., du Bois R., Melief C. J., Zeylemaker W. P., Raat-Koning L., de Groot-Kooy L. Lymphocyte activation and destruction in vitro in relation to MLC and HL-A. Transplant Proc. 1973 Sep;5(3):1301–1307. [PubMed] [Google Scholar]
  7. Garrido F., Festenstein H., Schirrmacher V. Further evidence for depression of H-2 and Ia-like specificities of foreign haplotypes in mouse tumour cell lines. Nature. 1976 Jun 24;261(5562):705–707. doi: 10.1038/261705a0. [DOI] [PubMed] [Google Scholar]
  8. Greaves M., Janossy G., Doenhoff M. Selective triggering of human T and B lymphocytes in vitro by polyclonal mitogens. J Exp Med. 1974 Jul 1;140(1):1–18. doi: 10.1084/jem.140.1.1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Hellström I., Hellström K. E., Sjögren H. O., Warner G. A. Demonstration of cell-mediated immunity to human neoplasms of various histological types. Int J Cancer. 1971 Jan 15;7(1):1–16. doi: 10.1002/ijc.2910070102. [DOI] [PubMed] [Google Scholar]
  10. Ihle J. N., Joseph D. R., Pazmino N. H. Radiation leukemia in C57BL/6 mice. II. Lack of ecotropic virus expression in the majority of lymphomas. J Exp Med. 1976 Dec 1;144(6):1406–1423. doi: 10.1084/jem.144.6.1406. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Ihle J. N., McEwan R., Bengali K. Radiation leukemia in C57BL/6 mice. I. Lack of serological evidence for the role of endogenous ecotropic viruses in pathogenesis. J Exp Med. 1976 Dec 1;144(6):1391–1405. doi: 10.1084/jem.144.6.1391. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Jondal M., Svedmyr E., Klein E., Singh S. Killer T cells in a Burkitt's lymphoma biopsy. Nature. 1975 May 29;255(5507):405–407. doi: 10.1038/255405a0. [DOI] [PubMed] [Google Scholar]
  13. Klein G. Experimental studies in tumor imminology. Fed Proc. 1969 Nov-Dec;28(6):1739–1753. [PubMed] [Google Scholar]
  14. OLD L. J., BOYSE E. A. IMMUNOLOGY OF EXPERIMENTAL TUMORS. Annu Rev Med. 1964;15:167–186. doi: 10.1146/annurev.me.15.020164.001123. [DOI] [PubMed] [Google Scholar]
  15. Opelz G., Kiuchi M., Takasugi M., Terasaki P. I. Autologous stimulation of human lymphocyte subpopulation. J Exp Med. 1975 Nov 1;142(5):1327–1333. doi: 10.1084/jem.142.5.1327. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Powles R. L., Crowther D., Bateman C. J., Beard M. E., McElwain T. J., Russell J., Lister T. A., Whitehouse J. M., Wrigley P. F., Pike M. Immunotherapy for acute myelogenous leukaemia. Br J Cancer. 1973 Nov;28(5):365–376. doi: 10.1038/bjc.1973.162. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Powles R. L., Lister T. A., Oliver R. T., Russell J., Smith C., Kay H. E., McElwain T. J., Fairley G. H. Safe method of collecting leukaemia cells from patients with acute leukaemia for use as immunotherapy. Br Med J. 1974 Nov 16;4(5941):375–379. doi: 10.1136/bmj.4.5941.375. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Powles R. L., Russell J., Lister T. A., Oliver T., Whitehouse J. M., Malpas J., Chapuis B., Crowther D., Alexander P. Immunotherapy for acute myelogenous leukaemia: a controlled clinical study 2 1/2 years after entry of the last patient. Br J Cancer. 1977 Mar;35(3):265–272. doi: 10.1038/bjc.1977.38. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Schendel D. J., Bach F. H. Genetic control of cell-mediated lympholysis in mouse. J Exp Med. 1974 Dec 1;140(6):1534–1546. doi: 10.1084/jem.140.6.1534. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Schlossman S. F., Chess L., Humphreys R. E., Strominger J. L. Distribution of Ia-like molecules on the surface of normal and leukemic human cells. Proc Natl Acad Sci U S A. 1976 Apr;73(4):1288–1292. doi: 10.1073/pnas.73.4.1288. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Sondel P. M., O'Brien C., Porter L., Schlossman S. F., Chess L. Cell-mediated destruction of human leukemic cells by MHC identical lymphocytes: requirement for a proliferative trigger in vitro. J Immunol. 1976 Dec;117(6):2197–2203. [PubMed] [Google Scholar]
  22. Takasugi M., Mickey M. R., Terasaki P. I. Studies on specificity of cell-mediated immunity to human tumors. J Natl Cancer Inst. 1974 Dec;53(6):1527–1538. [PubMed] [Google Scholar]
  23. Whitacre C., Lang R. W. Characterization of IgG-containing DEAE fractions of canine serum. Transplant Proc. 1975 Dec;7(4):531–536. [PubMed] [Google Scholar]
  24. Zarling J. M., Raich P. C., McKeough M., Bach F. H. Generation of cytotoxic lymphocytes in vitro against autologous human leukaemia cells. Nature. 1976 Aug 19;262(5570):691–693. doi: 10.1038/262691a0. [DOI] [PubMed] [Google Scholar]

Articles from The Journal of Experimental Medicine are provided here courtesy of The Rockefeller University Press

RESOURCES